Essais liés3clinical trials
VilleCzęstochowalocalisation
PaysPolandlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05648500

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Cenerimod Lupus Phase 3 NCT06475742 OPUS OLE — Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus ENROLLING_BY_INVITATION
Cenerimod Lupus Phase 3 NCT05648500 OPUS-1 — A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus ACTIVE_NOT_RECRUITING
Rimegepant 75mg daily dosing Migraine Phase 4 NCT05217927 Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens COMPLETED